HFM
AZN icon

Hartford Funds Management’s AstraZeneca AZN Stock Holding History

Hartford Funds Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Sell
5,837
-177
-3% -$34.1K 0.1% 59
2025
Q4 		$1.11M Sell
6,014
-103
-2% -$18.1K 0.09% 60
2025
Q3 		$939K Sell
6,117
-983
-14% -$149K 0.08% 47
2025
Q2 		$992K Buy
7,100
+658
+10% +$92.2K 0.09% 48
2025
Q1 		$947K Buy
6,442
+823
+15% +$119K 0.09% 49
2024
Q4 		$736K Buy
5,619
+299
+6% +$41.9K 0.07% 60
2024
Q3 		$829K Buy
5,320
+125
+2% +$20.2K 0.08% 52
2024
Q2 		$810K Buy
5,195
+475
+10% +$71.5K 0.08% 49
2024
Q1 		$640K Buy
4,720
+708
+18% +$93.8K 0.06% 54
2023
Q4 		$540K Buy
4,012
+1,117
+39% +$145K 0.05% 53
2023
Q3 		$392K Buy
2,895
+164
+6% +$22.4K 0.04% 48
2023
Q2 		$391K Buy
2,731
+336
+14% +$49.4K 0.04% 46
2023
Q1 		$332K Buy
2,395
+478
+25% +$64.3K 0.03% 52
2022
Q4 		$260K Buy
+1,917
New +$240K 0.03% 51

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Hartford Funds Management's AZN Position: Q1 2026 in Review

Hartford Funds Management reduced its AstraZeneca (AZN) stake by 2.9% in Q1 2026, selling an estimated $34.1K and leaving 5,837 shares worth $1.13M. The position accounts for 0.1% of the portfolio, ranked #59.

Hartford Funds Management first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Hartford Funds Management held 5,837 shares of AstraZeneca worth $1.13M as of Q1 2026.
  • Hartford Funds Management sold 177 AstraZeneca shares in Q1 2026, an estimated $34.1K.
  • AstraZeneca made up 0.1% of Hartford Funds Management's portfolio in Q1 2026, its #59 holding.
  • Hartford Funds Management first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Hartford Funds Management's 13F filing for Q1 2026, filed 4 May 2026.